Compare IONQ Inc (IONQ) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IONQ Inc vs McKesson Corporation — how do they compare? IONQ Inc trades at $39.89 (market cap $15.98B), while McKesson Corporation trades at $938.84 (market cap $108.46B). The key difference: McKesson Corporation is far larger — about 6.8× IONQ Inc's market cap, and McKesson Corporation pays a 0.4% dividend while IONQ Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold IONQ Inc for 33 Days and McKesson Corporation for 74 Days on average.
| IONQ | MCK | |
|---|---|---|
Market Cap | $15.98B | $108.46B |
Volume | 22,848,240 | 712,607 |
Sector | Technology | Health |
52-Week High | $82.09 | $995.69 |
52-Week Low | $26.59 | $725.17 |
Typical Hold Time | 33 Days | 74 Days |
Enterprise Value | $13.92B | $115.00B |
Dividend Yield | — | 0.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IONQ trades at $39.45, down 4.57% today, with bearish technical signals from moving averages but bullish oscillators. The company shows strong revenue growth ($130M in 2025 to $246M projected for 2026) but significant losses (-$510M net income in 2025). Recent Q2 2026 earnings missed expectations, while Q1 and Q4 2025 beat. Analyst consensus is split 50/50 buy/hold with a $62.75 price target, suggesting 59% upside potential from current levels.
IONQ presents high-risk, high-reward potential with substantial revenue growth offset by deep losses and negative margins. The quantum computing sector offers long-term upside if commercialization succeeds, but investors face dilution risk from continued cash burn and execution challenges in scaling technology. Current valuation multiples (P/S 54.74) appear stretched relative to profitability metrics.
McKesson (MCK) trades at $930.25, up 2.19% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue growth is robust, reaching $359.05B in 2025, though net margins are thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing long-term visibility.
The outlook is positive, driven by operational strength and strategic partnerships, but investors face risks from margin pressure and drug pricing uncertainty. With 81% of analysts rating it Buy and a consensus target of $956.43, the stock offers upside, though high RSI levels suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IONQ Inc
IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.
Read more on IONQ →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
